The Clorox Company(CLX) Stock Research - Grey Stern Research
Loading...

The Clorox Company (CLX) Stock Analysis

$165.95 (-0.19%)

CLX Financial Performance


Use the table below to view The Clorox Company's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q4 - 2024

Metric Value Ranking among Peers
Price $164.97 -
52 Week Low $114.69 -
52 Week High $167.75 -
Market Cap $20.4 Billion 6/6
Gross Margin 46% 4/6
Profit Margin 11% 3/6
EBITDA margin 31% 1/6
Q4 - 2024 Revenue $1.9 Billion 5/6
Q4 - 2024 Earnings $216.0 Million 4/6
Q4 - 2024 Free Cash Flow $0 Million 4/6
Trailing 4 Quarters Revenue $7.1 Billion 5/6
Trailing 4 Quarters Earnings $280.0 Million 6/6
Quarterly Earnings Growth 23% 3/6
Annual Earnings Growth 162% 1/6
Quarterly Revenue Growth -6% 6/6
Annual Revenue Growth -9% 6/6
Cash On Hand $202.0 Million 6/6
Short Term Debt $88.0 Million 4/6
Long Term Debt $2.5 Billion 5/6

The Clorox Company Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare The Clorox Company's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 72.98 2/6
PS 2.88 4/6
PB 41.53 2/6
PC 101.16 1/6
Liabilities to Equity 16.03 2/6
ROA 0.05 5/6
ROE 0.85 3/6
Current Ratio 1.09 4/6
Quick Ratio 0.04 6/6
Long Term Debt to Equity 7.56 2/6
Debt to Equity 8.85 2/6
Burn Rate -2.13 3/6
Cash to Cap 0.01 5/6
CCR 0.00 4/6
EV to EBITDA 39.68 5/6
EV to Revenue 3.26 4/6

Company Details

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

CEO: Mr. Benno Dorer

Website: https://www.thecloroxcompany.com

Address: 1221 Broadway Oakland, CALIFORNIA

Exchange: New York Stock Exchange

Industry: Household & Personal Products

The Clorox Company Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to The Clorox Company. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
The Procter & Gamble Company PG $409.0 Billion
Kimberly-Clark Corporation KMB $48.3 Billion
Colgate-Palmolive Company CL $86.1 Billion
Church & Dwight Co., Inc. CHD $25.8 Billion
The Estée Lauder Companies Inc. EL $30.3 Billion
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
CLX Income Statements
Quarter Year Revenue Earnings
Q4 2024 $ 1.9 Billion $216.0 Million
Q3 2024 $ 1.8 Billion -$51.0 Million
Q2 2024 $ 2.0 Billion $93.0 Million
Q1 2024 $ 1.4 Billion $22.0 Million
Q4 2023 $ 2.0 Billion $176.0 Million
Q3 2023 $ 1.9 Billion -$209.0 Million
Q2 2023 $ 1.7 Billion $99.0 Million
Q1 2023 $ 2.0 Million $85.0 Million

View All

CLX Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q4 2024 $202.0 Million $5.8 Billion $2.9 Billion $492.0 Million
Q3 2024 $219.0 Million $5.8 Billion $3.0 Billion $255.0 Million
Q2 2024 $355.0 Million $5.9 Billion $3.1 Billion $218.0 Million
Q1 2024 $518.0 Million $6.0 Billion $3.2 Billion -$37.0 Million
Q4 2023 $367.0 Million $5.9 Billion $2.9 Billion $220.0 Million
Q3 2023 $242.0 Million $5.8 Billion $3.0 Billion $3.0 Million
Q2 2023 $168.0 Million $6.0 Billion $3.1 Billion $321.0 Million
Q1 2023 $278.0 Million $6.2 Billion $3.2 Billion $496.0 Million

View All

CLX Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q4 2024 $0 $0 $0
Q3 2024 $127.0 Million -$55.0 Million -$137.0 Million
Q2 2024 $101.0 Million -$52.0 Million -$162.0 Million
Q1 2024 -$4.0 Million -$24.0 Million $152.0 Million
Q4 2023 $0 $0 $0
Q3 2023 $285.0 Million -$56.0 Million $76.0 Million
Q2 2023 $167.0 Million -$42.0 Million -$110.0 Million
Q1 2023 $132.0 Million -$46.0 Million $37.0 Million

View All